CROCS INC (CROX)

US2270461096 - Common Stock

140.95  -1.06 (-0.75%)

After market: 140.95 0 (0%)

Fundamental Rating

6

Overall CROX gets a fundamental rating of 6 out of 10. We evaluated CROX against 51 industry peers in the Textiles, Apparel & Luxury Goods industry. While CROX has a great profitability rating, there are some minor concerns on its financial health. CROX has a decent growth rate and is not valued too expensively.



9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
CROX had positive earnings in each of the past 5 years.
CROX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CROX has a Return On Assets of 16.59%. This is amongst the best in the industry. CROX outperforms 96.00% of its industry peers.
Looking at the Return On Equity, with a value of 49.81%, CROX belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
CROX's Return On Invested Capital of 21.10% is amongst the best of the industry. CROX outperforms 96.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 10.21%.
The last Return On Invested Capital (21.10%) for CROX is well below the 3 year average (30.08%), which needs to be investigated, but indicates that CROX had better years and this may not be a problem.
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROIC 21.1%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

CROX's Profit Margin of 19.80% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
CROX's Profit Margin has declined in the last couple of years.
CROX has a Operating Margin of 26.43%. This is amongst the best in the industry. CROX outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 56.16% is fine compared to the rest of the industry. CROX outperforms 72.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.

2.2 Solvency

CROX has an Altman-Z score of 4.10. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.10, CROX is doing good in the industry, outperforming 70.00% of the companies in the same industry.
The Debt to FCF ratio of CROX is 2.19, which is a good value as it means it would take CROX, 2.19 years of fcf income to pay off all of its debts.
CROX has a Debt to FCF ratio of 2.19. This is comparable to the rest of the industry: CROX outperforms 58.00% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CROX has dependencies on debt financing.
CROX has a worse Debt to Equity ratio (1.08) than 82.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 2.19
Altman-Z 4.1
ROIC/WACC2.28
WACC9.25%

2.3 Liquidity

A Current Ratio of 1.76 indicates that CROX should not have too much problems paying its short term obligations.
CROX has a Current ratio of 1.76. This is in the lower half of the industry: CROX underperforms 66.00% of its industry peers.
CROX has a Quick Ratio of 1.14. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX has a Quick ratio (1.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.14

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.46% over the past year.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.01% on average per year.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 6.29% in the last year.
The Revenue has been growing by 29.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5YN/A
EPS growth Q2Q15.71%
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Revenue growth Q2Q6.16%

3.2 Future

Based on estimates for the next years, CROX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.26% yearly.
EPS Next Y5.59%
EPS Next 2Y7.43%
EPS Next 3Y7.86%
EPS Next 5Y8.49%
Revenue Next Year4.18%
Revenue Next 2Y4.79%
Revenue Next 3Y4.94%
Revenue Next 5Y7.26%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated reasonably with a Price/Earnings ratio of 11.33.
Compared to the rest of the industry, the Price/Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 82.00% of the companies listed in the same industry.
CROX is valuated cheaply when we compare the Price/Earnings ratio to 28.60, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.15 indicates a reasonable valuation of CROX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 88.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CROX to the average of the S&P500 Index (20.15), we can say CROX is valued slightly cheaper.
Industry RankSector Rank
PE 11.33
Fwd PE 10.15

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than the industry average as 66.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 10.84
EV/EBITDA 9.05

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CROX does not grow enough to justify the current Price/Earnings ratio.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.03
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y7.86%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (5/17/2024, 7:00:01 PM)

After market: 140.95 0 (0%)

140.95

-1.06 (-0.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.56B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.33
Fwd PE 10.15
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.76
Quick Ratio 1.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y